NutriDex

The Supplement Research Compendium
🧠

Acetyl-L-Carnitine (ALCAR)

Acetylated carnitine studied for nerve pain, mood and aging brain.

Moderate evidence 🧠Nootropic⏳Longevity

✚ Updated · How we grade evidence

Evidence tier
Moderate
Research weight
Citations
10 verified / 10
Classification
Nootropic
❝
What the evidence says. Graded moderate: several meta-analyses are positive across nerve pain, depression and cognition, but the underlying trials are mostly small, older and heterogeneous (depression I2 86%), and the Cochrane neuropathy review rated its evidence 'very low certainty' — so benefits are plausible and modest, not firmly established. (Moderate evidence: Several controlled trials; effects real but modest or context-dependent.)

What is Acetyl-L-Carnitine (ALCAR)?

Acetyl-L-Carnitine (ALCAR) is a nootropic used for ease diabetic nerve pain. NutriDex grades the human evidence as Moderate. Acetyl-L-carnitine (ALCAR) is an acetylated form of carnitine that shuttles fatty acids into mitochondria and is more readily taken up by the brain than plain L-carnitine. Its best human evidence is for painful peripheral neuropathy: a 2015 meta-analysis of 4 RCTs (n=523) found a mean pain reduction of about 1.2 points on a 10-point scale versus placebo, with larger effects in diabetic patients, though a 2019 Cochrane review judged the evidence very low certainty. A 2018 meta-analysis (12 RCTs, 791 people) reported a moderate-to-large drop in depressive symptoms, but heterogeneity was high. Older trials suggest modest cognitive benefit in mild cognitive impairment and early Alzheimer's, and carnitine supplements improve some sperm parameters. Effect sizes vary widely and many trials are small or industry-linked, so ALCAR is a reasonable adjunct rather than a proven treatment.

Purported Benefits

✓Ease diabetic nerve pain
✓Reduce depressive symptoms
✓Support cognition in older adults
✓Improve sperm motility

Evidence by outcome

The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.

OutcomeEvidenceEffectStudies
Reduces diabetic/peripheral neuropathic pain2015 meta-analysis showed ~1.2-point pain drop, but 2019 Cochrane rated the same evidence 'very low certainty'. Mixed ↑ benefit · moderate 3
Reduces depressive symptoms12-RCT meta-analysis found a large effect (SMD -1.10) but very high heterogeneity (I2 86%) limits confidence. Moderate ↑ benefit · moderate 1
Improves cognition in MCI / mild Alzheimer's2003 meta-analysis showed a cognitive test benefit, but a Cochrane review found no meaningful slowing of dementia progression. Mixed ↔ mixed · small 2
Improves sperm motility in male infertility2024 meta-analysis (14 RCTs, 1,453 men) found improved total and forward motility in idiopathic infertility. Moderate ↑ benefit · moderate 1

Dosing & Compounds

Typical Dose
1,500–3,000 mg/day of acetyl-L-carnitine, usually split into 2–3 doses; neuropathy and cognition trials used the upper end.
Active Compounds
Acetyl-L-carnitineL-carnitine (metabolite)

Safety & Cautions

Generally well tolerated; the most common side effects are nausea, vomiting, abdominal cramps, diarrhea and a fishy body odor at higher doses, plus occasional agitation or insomnia. It may lower seizure threshold and has been linked to increased seizure frequency, so use caution in epilepsy. Carnitine can interact with thyroid hormone (it may blunt thyroid action, a concern in hypothyroidism) and theoretically with warfarin and other anticoagulants, raising bleeding risk; people on thyroid or blood-thinning medication should consult a clinician first. Long-term carnitine intake raises the gut metabolite TMAO, whose cardiovascular relevance is still debated. Educational only — always check with your doctor or pharmacist before combining Acetyl-L-Carnitine (ALCAR) with any medicine.

Key Studies ★ 10 studies

Meta-analysis Wang 2024 ✓ Full text
Meta-analysis (14 RCTs, 1,453 men): L-acetyl-carnitine improved total and forward sperm motility in idiopathic male infertility.
Meta-analysis Li 2015 ✓ PubMed
Meta-analysis of 4 RCTs (n=523): ALCAR cut neuropathic pain by ~1.2 VAS points vs placebo; larger in diabetic patients (MD 1.47).
Systematic review Rolim 2019 (Cochrane) ✓ PubMed
Cochrane review (4 RCTs, 907 patients): ALCAR reduced diabetic neuropathy pain (MD -14.9 VAS at >1500mg/day) but evidence was 'very low certainty'.
Meta-analysis Veronese 2018 ✓ PubMed
Meta-analysis of 12 RCTs (n=791): ALCAR lowered depressive symptoms vs placebo (SMD -1.10) with efficacy similar to antidepressants but high heterogeneity (I2 86%).
Meta-analysis Montgomery 2003 ✓ PubMed
Meta-analysis of double-blind RCTs (1.5–3 g/day) found a significant cognitive benefit of ALCAR over placebo in mild cognitive impairment and mild Alzheimer's.
Systematic review Hudson 2003 (Cochrane) ✓ PubMed
Cochrane review found no convincing evidence that ALCAR meaningfully slows clinical progression of dementia despite small test-score signals.
RCT Li 2016 ✓ PubMed
Multicenter double-blind RCT (n=232): ALCAR 1.5g/day matched methylcobalamin for improving diabetic neuropathy symptom and disability scores over 24 weeks.
Review Yang 2026 ✓ PubMed
Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications
Review Yoon 2026 ✓ PubMed
The Dynamic Coenzyme Network of B Vitamins in Nutritional Neuropathy and Neuropsychiatric Vulnerability: A Mechanistic Narrative Review
Review Pennisi 2020 ✓ PubMed
Critical update review concludes ALCAR shows neuroprotective and antidepressant signals but trials remain small, short and methodologically limited.
10 sources cited · 10 verified Search all studies on PubMed ↗

Common questions about Acetyl-L-Carnitine (ALCAR)

What is Acetyl-L-Carnitine (ALCAR) used for?

Acetyl-L-Carnitine (ALCAR) is most often taken for Ease diabetic nerve pain, Reduce depressive symptoms, Support cognition in older adults, Improve sperm motility. Acetylated carnitine studied for nerve pain, mood and aging brain.

Does Acetyl-L-Carnitine (ALCAR) work — what does the evidence say?

Moderate evidence. Several controlled trials; effects real but modest or context-dependent. Acetyl-L-carnitine (ALCAR) is an acetylated form of carnitine that shuttles fatty acids into mitochondria and is more readily taken up by the brain than plain L-carnitine. Its best human evidence is for painful peripheral neuropathy: a 2015 meta-analysis of 4 RCTs (n=523) found a mean pain reduction of about 1.2 points on a 10-point scale versus placebo, with larger effects in diabetic patients, though a 2019 Cochrane review judged the evidence very low certainty. A 2018 meta-analysis (12 RCTs, 791 people) reported a moderate-to-large drop in depressive symptoms, but heterogeneity was high. Older trials suggest modest cognitive benefit in mild cognitive impairment and early Alzheimer's, and carnitine supplements improve some sperm parameters. Effect sizes vary widely and many trials are small or industry-linked, so ALCAR is a reasonable adjunct rather than a proven treatment.

What is the typical dose of Acetyl-L-Carnitine (ALCAR)?

1,500–3,000 mg/day of acetyl-L-carnitine, usually split into 2–3 doses; neuropathy and cognition trials used the upper end.

Is Acetyl-L-Carnitine (ALCAR) safe? Any cautions or side effects?

Generally well tolerated; the most common side effects are nausea, vomiting, abdominal cramps, diarrhea and a fishy body odor at higher doses, plus occasional agitation or insomnia. It may lower seizure threshold and has been linked to increased seizure frequency, so use caution in epilepsy. Carnitine can interact with thyroid hormone (it may blunt thyroid action, a concern in hypothyroidism) and theoretically with warfarin and other anticoagulants, raising bleeding risk; people on thyroid or blood-thinning medication should consult a clinician first. Long-term carnitine intake raises the gut metabolite TMAO, whose cardiovascular relevance is still debated.

How many studies support Acetyl-L-Carnitine (ALCAR)?

NutriDex cites 10 sources for Acetyl-L-Carnitine (ALCAR), graded "Moderate".

Cite this page
APA

Peh, D. (2026). Acetyl-L-Carnitine (ALCAR): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 10 Aug 2026, from https://nutridex.info/s/acetyl-l-carnitine

BibTeX
@misc{nutridex_acetyl_l_carnitine,
  author       = {Peh, Daryl},
  title        = {Acetyl-L-Carnitine (ALCAR): Benefits, Dosage, Side Effects \& Evidence},
  year         = {2026},
  howpublished = {NutriDex --- The Supplement Research Compendium},
  url          = {https://nutridex.info/s/acetyl-l-carnitine},
  note         = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-08-10}
}

For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.

← Back to the full dex · All substances